Pfizer Inc
In its 13F for Q3 2025 (holdings as of September 30, 2025, filed November 13, 2025), Pfizer Inc reported 21 stock positions worth $437.5 million. Its top holding was Biontech SE-ADR (BNTX) at 37.4% of the portfolio, followed by Oric Pharmaceuticals (ORIC, 14.7%) and Tourmaline Bio (TRML, 13.9%). Compared with Q2 2025, it added to 1 and reduced 1. The biggest buy was Nextcure (NXTC, shares +1102%) and the biggest sale Biontech SE-ADR (BNTX, shares −55%).
- Most Recent 13F
- Q2 2026
- Location
- New York, NY
- CIK
- 0000078003
- Portfolio Value
- $437.5M (Q3 2025)
- SEC Filing
- 0000078003-25-000161 ↗ filed Nov 13, 2025
Holdings Value
Holdings 21 stocks · $437.5M
| BNTX Biontech SE-ADR | 37.39% | 1,658,361 | $163.5M | Reduce -54.7% |
| ORIC Oric Pharmaceuticals Inc. | 14.75% | 5,376,344 | $64.5M | No change |
| TRML Tourmaline Bio Inc. | 13.91% | 1,272,214 | $60.8M | No change |
| ARVN Arvinas Inc. | 6.73% | 3,457,815 | $29.5M | No change |
| ALLO Allogene Therapeutics Inc. | 6.25% | 22,032,040 | $27.3M | No change |
| CELC Celcuity Inc. | 3.95% | 349,406 | $17.3M | No change |
| PYXS Pyxis Oncology Inc. | 3.57% | 7,032,770 | $15.6M | No change |
| WVE Wave Life Sciences Ltd. | 3.14% | 1,875,000 | $13.7M | No change |
| ZURA Zura Bio Ltd. | 2.94% | 2,970,022 | $12.9M | No change |
| CRBU Caribou Biosciences Inc. | 2.50% | 4,690,431 | $10.9M | No change |
| BHVN Biohaven Ltd. | 1.74% | 505,645 | $7.6M | No change |
| CRDF Cardiff Oncology Inc. | 1.14% | 2,411,575 | $5.0M | No change |
| SPRO Spero Therapeutics Inc. | 1.02% | 2,362,348 | $4.4M | No change |
| ZNTL Zentalis Pharmaceuticals Inc. | 0.33% | 953,834 | $1.4M | No change |
| NXTC Nextcure Inc. | 0.21% | 157,646 | $924K | Add +1101.7% |
| ANTX AN2 Therapeutics Inc. | 0.21% | 715,295 | $908K | No change |
| QTTB Q32 Bio Inc. | 0.13% | 277,777 | $550K | No change |
| EPIX Essa Pharma Inc. | 0.07% | 1,675,000 | $320K | No change |
| BOLT Bolt Biotherapeutics Inc. | 0.04% | 31,305 | $167K | No change |
| DNA Ginkgo Bioworks Holdings Inc. | 0.01% | 2,928 | $43K | No change |
| SENS Senseonics Holdings Inc. | 0.00% | 43,426 | $19K | No change |
Portfolio Sells Q2 2025 → Q3 2025
| BNTX Biontech SE-ADR | Reduce -54.7% | 37.39% | −30.21 |
Portfolio Buys Q2 2025 → Q3 2025
| NXTC Nextcure Inc. | Add +1101.7% | 0.21% | +0.06 |
All Filings
| Quarter | Positions | 13F Reported Value | Top Holdings |
|---|---|---|---|
| Q2 2026 | 17 | $170.4M | ALLO, CELC, ARVN, PYXS, WVE |
| Q1 2026 | 18 | $238.8M | ORIC, ALLO, ARVN, CELC, ZURA |
| Q4 2025 | 18 | $236.5M | ORIC, ARVN, CELC, WVE, ALLO |
| Q3 2025 | 21 | $437.5M | BNTX, ORIC, TRML, ARVN, ALLO |
| Q2 2025 | 21 | $576.2M | BNTX, ORIC, ARVN, ALLO, TRML |
| Q1 2025 | 21 | $500.8M | BNTX, ALLO, ORIC, ARVN, TRML |
| Q4 2024 | 23 | $2.6B | HLN, BNTX, ARVN, ALLO, ORIC |